Literature DB >> 21426337

Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.

Mark T Whary1, Nancy S Taylor, Yan Feng, Zhongming Ge, Suresh Muthupalani, James Versalovic, James G Fox.   

Abstract

To model inflammatory bowel disease, we assessed infection with Helicobacter hepaticus 3B1 (ATCC 51449) and a potential probiotic Lactobacillus reuteri (ATCC PTA-6475) in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. No typhlocolitis developed in germ-free controls (n=21) or in L. reuteri (n=8) or H. hepaticus (n=18) mono-associated mice for 20 weeks post-infection. As positive controls, three specific pathogen-free IL-10(-/-) mice dosed with H. hepaticus developed severe typhlocolitis within 11 weeks. Because L. reuteri PTA-6475 has anti-inflammatory properties in vitro, it was unexpected to observe significant typhlocolitis (P<0·0001) in mice that had been infected with L. reuteri followed in 1 week by H. hepaticus (n=16). The H. hepaticus colonization was not affected through 20 weeks post-infection but L. reuteri colonization was lower in co-infected compared with L. reuteri mono-associated mice at 8-11 weeks post-infection (P<0·05). Typhlocolitis was associated with an increased T helper type 1 serum IgG2c response to H. hepaticus in co-infected mice compared with H. hepaticus mono-associated mice (P<0·005) and similarly, mRNA expression in caecal-colonic tissue was elevated at least twofold for chemokine ligands and pro-inflammatory interleukin-1α (IL-1α), IL-1β, IL-12 receptor, tumour necrosis factor-α and inducible nitric oxide synthase. Anti-inflammatory transforming growth factor-β, lactotransferrin, peptidoglycan recognition proteins, Toll-like receptors 4, 6, 8 and particularly 9 gene expression, were also elevated only in co-infected mice (P<0·05). These data support that the development of typhlocolitis in H. hepaticus-infected IL-10(-/-) mice required co-colonization with other microbiota and in this study, required only L. reuteri. Although the effects other microbiota may have on H. hepaticus virulence properties remain speculative, further investigations using this gnotobiotic model are now possible.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21426337      PMCID: PMC3088979          DOI: 10.1111/j.1365-2567.2011.03423.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  55 in total

1.  Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus.

Authors:  J M Ward; M R Anver; D C Haines; J M Melhorn; P Gorelick; L Yan; J G Fox
Journal:  Lab Anim Sci       Date:  1996-02

2.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.

Authors:  R J Cahill; C J Foltz; J G Fox; C A Dangler; F Powrie; D B Schauer
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.

Authors:  Leisa Mandell; Anthony P Moran; Andrew Cocchiarella; JeanMarie Houghton; Nancy Taylor; James G Fox; Timothy C Wang; Evelyn A Kurt-Jones
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells.

Authors:  Claudia Di Giacinto; Mariarosaria Marinaro; Massimo Sanchez; Warren Strober; Monica Boirivant
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

6.  In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants.

Authors:  Vincent B Young; Kimberly A Knox; Jason S Pratt; Jennifer S Cortez; Linda S Mansfield; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

9.  Helicobacter-induced chronic active lymphoid aggregates have characteristics of tertiary lymphoid tissue.

Authors:  Nirah H Shomer; James G Fox; Amy E Juedes; Nancy H Ruddle
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis.

Authors:  J G Fox; X Li; L Yan; R J Cahill; R Hurley; R Lewis; J C Murphy
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  20 in total

1.  Helicobacter saguini, a Novel Helicobacter Isolated from Cotton-Top Tamarins with Ulcerative Colitis, Has Proinflammatory Properties and Induces Typhlocolitis and Dysplasia in Gnotobiotic IL-10-/- Mice.

Authors:  Z Shen; A Mannion; M T Whary; S Muthupalani; A Sheh; Y Feng; G Gong; P Vandamme; H R Holcombe; B J Paster; J G Fox
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

2.  Effects of Colonization of Gnotobiotic Swiss Webster Mice with Helicobacter bilis.

Authors:  Mark T Whary; Chuanwu Wang; Catherine F Ruff; Mallory J DiVincenzo; Caralyn Labriola; Lillian Ge; Yan Feng; Zhongming Ge; Vasu Bakthavatchalu; Suresh Muthupalani; Bruce H Horwitz; James G Fox
Journal:  Comp Med       Date:  2020-04-29       Impact factor: 0.982

Review 3.  Understanding immune-microbiota interactions in the intestine.

Authors:  Philip P Ahern; Kevin J Maloy
Journal:  Immunology       Date:  2019-11-27       Impact factor: 7.397

4.  Coinfection with Enterohepatic Helicobacter species can ameliorate or promote Helicobacter pylori-induced gastric pathology in C57BL/6 mice.

Authors:  Zhongming Ge; Yan Feng; Sureshkumar Muthupalani; Laura Lemke Eurell; Nancy S Taylor; Mark T Whary; James G Fox
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

5.  Helicobacter pylori and enteric parasites co-infection among diarrheic and non-diarrheic Egyptian children: seasonality, estimated risks, and predictive factors.

Authors:  Asmaa Ibrahim; Yasser B M Ali; Amal Abdel-Aziz; Ayman A El-Badry
Journal:  J Parasit Dis       Date:  2019-01-01

6.  The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota.

Authors:  Annah S Rolig; Cynthia Cech; Ethan Ahler; J Elliot Carter; Karen M Ottemann
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 7.  Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.

Authors:  Avijit Ray; Bonnie N Dittel
Journal:  Immunology       Date:  2015-09-07       Impact factor: 7.397

8.  Helicobacter hepaticus Induce Colitis in Male IL-10-/- Mice Dependent by Cytolethal Distending Toxin B and via the Activation of Jak/Stat Signaling Pathway.

Authors:  Liqi Zhu; Chen Zhu; Shuyang Cao; Quan Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-12       Impact factor: 5.293

9.  Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis.

Authors:  Ines Yang; Daniel Eibach; Friederike Kops; Birgit Brenneke; Sabrina Woltemate; Jessika Schulze; André Bleich; Achim D Gruber; Sureshkumar Muthupalani; James G Fox; Christine Josenhans; Sebastian Suerbaum
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

Review 10.  A Multihit Model: Colitis Lessons from the Interleukin-10-deficient Mouse.

Authors:  Lydia M Keubler; Manuela Buettner; Christine Häger; André Bleich
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.